Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04294277
Title Safety and Efficacy of Pemigatinib in Patients With High-risk Urothelial Cancer After Radical Surgery (PEGASUS)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors European Association of Urology Research Foundation

ureter transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma



Age Groups: adult | senior
Covered Countries ITA

Additional content available in CKB BOOST